Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Apr 29;17(11):1662–1672. doi: 10.1016/j.bbmt.2011.04.008

Figure 5. Effect of KIR expression status before CMV reactivation.

Figure 5

A) shows the percent cumulative CMV incidence in the presence or absence of KIR2DS2 expression before CMV reactivation (log-rank test p=0.45) and B) shows the same plot applied to KIR2DS4 (log-rank test p= 0.51). C) shows only the presence of expression ( greater than 0) for either 2DS2, or 2DS4, or 2DS2+2DS4 before CMV reactivation (log-rank test p=0.04).